Ajanta Pharma Limited
HDFC Mutual Fund trimmed its stake in Ajanta Pharma from 1.14% to 1.01%, selling 1,57,264 shares.
A manufacturer of specialty pharmaceutical finished dosages, this company develops and markets formulations across therapeutic categories including ophthalmology, gastroenterology, and dermatology for domestic and international markets. With vertically integrated operations spanning development, manufacturing, and marketing, the company has established a significant presence in India's pharmaceutical sector through its robust distribution network and focus on quality production.
One of India's oldest and most trusted AMCs with over Rs 7.5 lakh crore in AUM. Founded in 1999 as a joint venture between HDFC Bank and Standard Life. MD and CEO Navneet Munot, formerly CIO of SBI MF, has reinforced the quality and compounding philosophy across equity schemes. HDFC Flexi Cap Fund and HDFC Mid-Cap Opportunities Fund are among the largest actively managed equity schemes in India.